Form 8-K - Current report:
SEC Accession No. 0000950123-05-011500
Filing Date
2005-09-26
Accepted
2005-09-26 17:09:01
Documents
9
Period of Report
2005-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y13070e8vk.htm 8-K 28564
2 EX-10.1: SERVICE CONTRACT y13070exv10w1.htm EX-10.1 51051
3 EX-10.2: COMPENSATORY ARRANGEMENTS y13070exv10w2.htm EX-10.2 12511
4 EX-10.3: CHANGE IN CONTROL AGREEMENT y13070exv10w3.htm EX-10.3 6283
5 EX-10.4: AMENDED LETTER AGREEMENT y13070exv10w4.htm EX-10.4 22965
6 EX-10.5: AMENDED CHANGE IN CONTROL AGREEMENT y13070exv10w5.htm EX-10.5 5893
7 EX-99.1: PRESS RELEASE y13070exv99w1.htm EX-99.1 14846
8 EX-99.2: PRESS RELEASE y13070exv99w2.htm EX-99.2 7451
9 EX-99.3: PRESS RELEASE y13070exv99w3.htm EX-99.3 10379
  Complete submission text file 0000950123-05-011500.txt   161631
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 051103412
SIC: 2835 In Vitro & In Vivo Diagnostic Substances